All Reports Events Blogs Videos
Showing 21 results
  • PEAK Matrix®
    June 02, 2025

    Life sciences enterprises are embracing digital technologies to navigate the growing complexities in drug development, commercialization, and regulatory compliance. As economic pressures and competitive dynamics intensify, organizations are turning to digital services to improve operational resilience…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Provider Compendium
    Aug. 22, 2025

    The increasing adoption of AI, generative AI, analytics, and industry-specific solutions across drug development, commercialization, and regulatory compliance is driving the rapid growth of digital services in the life sciences sector. Enterprises are turning to these…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • PEAK Matrix®
    Sep. 27, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. Therefore, there has been a conscious shift in enterprise mindset to focus on delivering products and services in…
  • Provider Compendium
    Nov. 21, 2022

    The pandemic necessitated and accelerated the rapid adoption of digital services across the Life Sciences (LS) value chain. As a result, there has been a shift in enterprise mindset to become more customer-centric and invest in…
  • Provider Compendium
    Feb. 12, 2021

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, ranging from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. There has also been a…
  • PEAK Matrix®
    Dec. 10, 2020

    The Life Sciences (LS) industry has been at the forefront of the COVID-19 response, from carrying out drug trials and vaccine development to producing Personal Protective Equipment (PPE) and ventilators. The industry was already growing significantly…
  • PEAK Matrix®
    Sep. 13, 2019

    The life sciences industry is plagued by issues such as high time-to-market for drugs and high costs of drug development. Enterprises have prioritized digital technologies in their corporate strategies to optimize processes, reduce costs, and positively…
  • Thematic Report
    Oct. 05, 2018

    The Industry Trends reports provide industry-specific data, developments, and insights that enable global sourcing managers to navigate through the complexity and make clear and effective decisions suited to their specific industries. These reports provide detailed information…
  • PEAK Matrix®
    Aug. 28, 2018

    The Life Sciences (LS) industry is now beginning to look at digital transformation more seriously. The European LS market has a number of distinctive characteristics, including price regulations, need for General Data Protection Regulation (GDPR) and…
  • PEAK Matrix®
    June 15, 2018

    The Life Sciences (LS) industry is now beginning to look at digital transformation seriously. With the advent of omni-channel information through IoT devices, mobility, and social media, consumers are gaining access to innovative ways of managing…
  • Thematic Report
    March 01, 2018

    The United States healthcare market experienced a tectonic shift in 2017, with President Trump’s (thus far unsuccessful) pursuit to repeal the Affordable Care Act (ACA) and replace it with a new law. Given the uncertainty of…
  • PEAK Matrix®
    May 31, 2017

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • Provider Compendium
    March 03, 2016

    Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…
  • PEAK Matrix®
    Sep. 22, 2016

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • PEAK Matrix®
    Sep. 07, 2016

    Introduction The Healthcare and Life Sciences (HLS) industry has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm…
  • PEAK Matrix®
    July 22, 2016

    The Healthcare and Life Sciences (HLS) landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with…
  • PEAK Matrix®
    July 13, 2015

    Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…
  • PEAK Matrix®
    June 22, 2015

    Introduction The healthcare landscape has been subject to significant turbulence on account of a gamut of factors including escalating costs, widespread regulatory amendments, changing business models, and evolution of the patient-centric paradigm (with mobile computing, social…

Items per page